Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $275 | $238 | $291 | $240 |
| % Growth | 15.8% | -18.3% | 20.9% | – |
| Cost of Goods Sold | $106 | $92 | $129 | $93 |
| Gross Profit | $169 | $146 | $161 | $148 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $137 | $123 | $124 | $119 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $137 | $123 | $124 | $119 |
| Operating Income | $33 | $23 | $37 | $28 |
| % Margin | 11.8% | 9.7% | 12.7% | 11.8% |
| Other Income/Exp. Net | $10 | $3 | $23 | $14 |
| Pre-Tax Income | $43 | $26 | $60 | $42 |
| Tax Expense | $11 | $8 | $7 | $11 |
| Net Income | $30 | $18 | $53 | $31 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS | 0.11 | 0.06 | 0.18 | 0.11 |
| % Growth | 82.7% | -66.6% | 63.6% | – |
| EPS Diluted | 0.11 | 0.06 | 0.18 | 0.1 |
| Weighted Avg Shares Out | 288 | 292 | 293 | 292 |
| Weighted Avg Shares Out Dil | 289 | 292 | 293 | 293 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $4 | $5 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $12 | $12 | $12 | $10 |
| EBITDA | $55 | $38 | $72 | $53 |
| % Margin | 20% | 15.8% | 24.8% | 21.9% |